Our attorneys are currently representing numerous women whose injuries were allegedly caused by products manufactured by these and several other companies.
New York, NY (PRWEB) January 31, 2015
The number of transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) now pending in New Jersey Superior Court has surpassed 9,100 between two separate litigations that are currently underway in Bergen County, Bernstein Liebhard LLP reports.
According to Case Lists updated on January 24th, 2015, nearly 7,500 Gynecare mesh lawsuits have been consolidated in a proceeding established for cases against the Johnson & Johnson subsidiary, Ethicon Inc., while more than 1,600 have been filed in the docket that includes claims involving C.R. Bard mesh implants. All the claims now centralized in both Bergen County litigations were filed by women who allege mesh erosion, chronic pain, infection and other injuries allegedly caused by devices they received to treat pelvic organ prolapse (POP) or stress urinary incontinence (SUI). (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
“We are pleased that both the C.R. Bard and Ethicon litigations in New Jersey are continuing to progress. Our attorneys are currently representing numerous women whose injuries were allegedly caused by products manufactured by these and several other companies,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free and confidential lawsuit evaluations to women who were allegedly harmed by products manufactured by C.R. Bard, Ethicon, Boston Scientific Corp. and American Medical Systems.
Transvaginal Mesh Lawsuits
According to court documents, the nationwide litigation involving transvaginal mesh has moved forward dramatically in recent years as women continue to file lawsuits that allege serious vaginal mesh complications. The U.S. Food and Drug Administration (FDA) issued its first warning about these risks in 2008, in which they categorized the potential for mesh erosion and other problems as “rare.” Three years later, the federal agency reported in a second alert that 3,000 additional complaints had been logged in its database. As a result, the FDA said in its July 2011 warning that vaginal mesh complications were “not rare.”
The FDA most recently addressed the risks associated with transvaginal mesh in April 2014, when officials proposed new regulations that would reclassify the pelvic implants as “high risk.” If the new rules go into effect, manufacturers would need to adhere to greater regulatory oversight and submit their devices for rigorous safety testing in order to receive pre-market approval.
Meanwhile, transvaginal mesh lawsuits are continuing to move forward in New Jersey’s Bergen County Superior Court. Jeffrey S. Grand, a partner at Bernstein Liebhard LLP is actively serving as Co-Liaison Counsel in both the C.R. Bard and Ethicon proceedings. In the Ethicon litigation, Mr. Grand also served on the Plaintiff’s trial team in a case that concluded with an $11 damage award to a woman whose injuries were found to be caused by a Gynecare Prolift implant she received. The trial concluded in March 2013.
At the federal level, Mr. Grand is also serving on the Plaintiffs’ Steering Committees in seven multidistrict litigations in the U.S. District Court, Southern District of West Virginia that together include more than 67,000 lawsuits, according to court documents. These proceedings include: In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2187; Coloplast Corp. Pelvic Support Systems Products Liability Litigation - MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2440; and In Re: Neomedic Pelvic Repair System Products Liability Litigation - MDL No. 2511.
Alleged victims of serious vaginal mesh complications may be entitled to compensation for their injury-related damages. Learn more about filing a transvaginal mesh lawsuit at Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
*http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm395192.htm, U.S. Food and Drug Administration (FDA), April 29, 2014.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP